In the realm of oncology, the concept of 'metabolic rewiring' has expanded beyond aerobic glycolysis to encompass various metabolic strategies that cancer cells employ for survival and progression, ...
The Bcl-2 inhibitor venetoclax is highly effective and is another first- or second-line option even if this agent, like BTK inhibitors, also appears to require continuous dosing, said Stadtmauer, ...
Adding durvalumab to chemotherapy significantly improved median progression-free survival (PFS) but not median overall survival (OS), while dual checkpoint blockade boosted both PFS and OS. These ...
Tanya Gupta, MD, medical oncologist in the Stanford University Department of Medicine, Division of Medical Oncology, evaluates fam-trastuzumab deruxtecan-nxki (Enhertu; T-DXd) and its role in breast ...
A phase three UK trial found that a new approach to administering chemotherapy to cervical cancer patients improved survival risk. Researcher Dr. Mary McCormack and gynecologic oncologist Dr. Brian ...